Antwerpen, Belgium

Ulrike Philippar

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Janssen Research & Development, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrike Philippar. Retrieved from https://idiyas.com/inventor/ulrike-philippar-h41rl2e5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulrike Philippar: Innovator in Antibody Development

Introduction

Ulrike Philippar is a prominent inventor based in Antwerpen, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. Her work focuses on creating advanced antibodies that target specific proteins involved in various diseases.

Latest Patents

Ulrike holds a patent for a groundbreaking invention titled "Trispecific Antibody Targeting BCMA, GPRC5D, and CD3." This innovative antibody is designed to enhance the immune response against certain cancer cells, showcasing her commitment to advancing medical science.

Career Highlights

Ulrike is currently employed at Janssen Research & Development, a subsidiary of Johnson & Johnson. Her role involves extensive research and development in the field of immunotherapy, where she applies her expertise to create effective treatment options for patients.

Collaborations

Throughout her career, Ulrike has collaborated with notable colleagues, including Ricardo Marcos Attar and Scott Ronald Brodeur. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ulrike Philippar's contributions to antibody development exemplify her dedication to improving healthcare through innovative research. Her work continues to inspire advancements in biotechnology and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…